Literature DB >> 8832222

Evidence that most high-affinity ATP binding sites on aortic endothelial cells and membranes do not correspond to P2 receptors.

S Motte1, S Swillens, J M Boeynaems.   

Abstract

It has recently been demonstrated that two types of ATP receptors, the P2Y and P2U receptors, are coexpressed on bovine aortic endothelial cells. The aim of the present study was to characterize directly P2Y and P2U subtypes on intact bovine aortic endothelial cells and on membranes prepared from these cells using adenosine 5'-0-(3-thio[35S]triphosphate) ([35S]ATP gamma S), [alpha-32P]ATP and [alpha-32P]UTP as radioligands. [35S]ATP gamma S binding to bovine aortic endothelial cell membranes was saturable and apparently involved a single class of high-affinity binding sites (Kd: 14 +/- 11 nM. Bmax 1.6 +/- 0.7 pmol/mg protein; mean +/- S.D.). A similar class of high-affinity binding sites was identified with [alpha-32P]ATP (Kd: 14 +/- 9 nM; Bmax: 1.7 +/- 1.1 pmol/mg protein; mean +/- S.D.). Competition experiments showed that only one third of these sites bound 2-methylthio-ATP (2-MeSATP) with high affinity (Ki: 21 +/- 5 and 14 +/- 10 nM, mean +/- S.D., for [35S]ATP gamma S and [alpha-32P]ATP, respectively) and might therefore represent the P2Y receptors. UTP did not compete with [35S]ATP gamma S or [alpha-32P]ATP for binding at the remaining sites, indicating that they are not the P2U receptors. No high-affinity UTP binding sites could be detected using [alpha-32P]UTP. [35S]ATP gamma S binding to intact bovine aortic endothelial cells was competed by ATP gamma S (Kd: 1.0 +/- 0.5 microM; mean +/- S.D.), but not by 2-MeSATP and UTP, indicating that these binding sites are neither the P2Y nor the P2U receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832222     DOI: 10.1016/0014-2999(96)00234-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.

Authors:  Gary L Waldo; James Corbitt; José L Boyer; Gnana Ravi; Hak Sung Kim; Xiao-Duo Ji; James Lacy; Kenneth A Jacobson; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

2.  The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.

Authors:  T E Webb; E Feolde; P Vigne; J T Neary; A Runberg; C Frelin; E A Barnard
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.